A MenB vaccine may also help curb drug-resistant gonorrhoea, linking two growing health threats and raising new questions about how vaccines are used.
Read more from the Department of Paediatrics' Charlie Firth ⬇️
https://t.co/YuU1R0BV2W
NEWS | The Oxford Vaccine Group are proud to share landmark findings from an Oxford-led study, published today in The New England Journal of Medicine.
🔗 Find the article in full on the Oxford Vaccine Group website, linked in the thread below, or head directly to the NEJM page
I’m pleased to see this new paper that explores how we can improve the dissemination of public health information by learning from global health communication practices published!
🔗 https://t.co/inJTcSDdKx
📢We're excited to share our newly published paper:
Communicating public health information to a global audience: an evaluation of methods to overcome barriers using a community-focussed approach
📝 Read it here: https://t.co/Ur4vPEgagz
🦠 It’s deadly. It’s airborne. And 2 billion people live in at-risk regions.
Nipah virus hasn’t made many headlines yet, but scientists are racing to develop vaccines before the next outbreak. https://t.co/aZs9dumplr
NEWS | Over the weekend, multiple news sources reported that Liverpool's Alder Hay Children's Hospital had confirmed the passing of a child after they had contracted measles.
🔗 Head to the Vaccine Knowledge website to learn more about Measles and the MMR vaccine, linked below
📢 The UK is proud to pledge new support to @Gavi �� helping protect millions of children from deadly diseases.
Our Minister for Development @JennyChapman visited @GSK this week, where British scientists are developing vaccines used by Gavi around the world 💉�📢 The UK is proud to pledge new support to @Gavi �� helping protect millions of children from deadly diseases.
Our Minister for Development @JennyChapman visited @GSK this week, where British scientists are developing vaccines used by Gavi around the world 💉�📢 The UK is proud to pledge new support to @Gavi �� helping protect millions of children from deadly diseases.
Our Minister for Development @JennyChapman visited @GSK this week, where British scientists are developing vaccines used by Gavi around the world 💉�📢 The UK is proud to pledge new support to @Gavi �� helping protect millions of children from deadly diseases.
Our Minister for Development @JennyChapman visited @GSK this week, where British scientists are developing vaccines used by Gavi around the world 💉�📢 The UK is proud to pledge new support to @Gavi �� helping protect millions of children from deadly diseases.
Our Minister for Development @JennyChapman visited @GSK this week, where British scientists are developing vaccines used by Gavi around the world 💉🌍
1 Billion children vaccinated, 18 million lives saved and $250 billion injected into the global economy.
The UK is proud to partner with @Gavi to make it happen. Our investment will boost growth, protect us from deadly diseases and save up to 8 million lives by 2030.
Excited to share a new co-author paper in Frontiers in Big Data:
“LISTEN: Lived Experiences of Long COVID”
We used social media data + digital ethnography to explore how people manage symptoms, mental health, & supplements in the face of uncertainty.
🔗 https://t.co/P0b2KfCDw7
Gonorrhoea: would you take a vaccine?
If you are a 13 or 14 year old or the parent of a child this age, 18-24 years old, or a sexual health service user, we want to hear from you!
The survey should take roughly 10-15 minutes to completeGonorrhoea: would you take a vaccine?
If you are a 13 or 14 year old or the parent of a child this age, 18-24 years old, or a sexual health service user, we want to hear from you!
The survey should take roughly 10-15 minutes to completeGonorrhoea: would you take a vaccine?
If you are a 13 or 14 year old or the parent of a child this age, 18-24 years old, or a sexual health service user, we want to hear from you!
The survey should take roughly 10-15 minutes to completeGonorrhoea: would you take a vaccine?
If you are a 13 or 14 year old or the parent of a child this age, 18-24 years old, or a sexual health service user, we want to hear from you!
The survey should take roughly 10-15 minutes to complete.
🚨 Funded #PhD Alert! 🚨 Tackle #Biofilms & #AMR in industrial laundry systems 🌍
2 projects: 🔬 Field-based w/ industry placements 🧪 Lab-based model development
📍UK + international placements 🎓 Start: Oct 2025 🔗 https://t.co/hY1OSTSZAp
🎉 New paper published in Vaccine.
With 281M STI cases in 2020, and drug-resistant gonorrhoea rising, a vaccine is urgently needed.
The gonorrhoea human challenge model could accelerate development, but how feasible is it?
Well, find out here: https://t.co/xWqFENjiRQ
Our latest data shows a rise in antibiotic-resistant #Gonorrhoea cases, particularly in popular tourist destinations across the Asia-Pacific region 🌴
Read our blog post for details of how to avoid catching gonorrhoea and how to identify the symptoms: https://t.co/dBUx3YUzhd
📢This Thursday!
Don't miss the opportunity to hear from @CharlieLFirth@OxfordVacGroup speaking about his research on parental attitudes to changing #vaccination schedules in Nepal.🇳🇵💉
📅 20 March
⏲️12.50 GMT
📍LSHTM | online
🔗https://t.co/IKX3cpZ3hd
🎉 New paper published in Vaccine.
With 281M STI cases in 2020, and drug-resistant gonorrhoea rising, a vaccine is urgently needed.
The gonorrhoea human challenge model could accelerate development, but how feasible is it?
Well, find out here: https://t.co/xWqFENjiRQ
With the rise in access to social media, the spread of misinformation has flourished. Mainstream media must step up, fact-check, and engage the public to protect health and trust. #Misinformation#MediaResponsibility
https://t.co/qEm5diGOfj